Clinical Trial Update: Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing eupatilin and rebamipide for prevention of gastroenteropathy, sponsored by Seoul National University Boramae Hospital; status n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Enteritis
• Gastric Ulcer
• Nsaid-associated Gastropathy
• Nsaid-induced Enteropathy
• Osteoarthritis
• Other Musculoskeletal Disorder
• Rheumatoid Arthritis

Drugs mentioned

• Eupatilin (eupatilin)
• Rebamipide (rebamipide)

Snippet

Sponsor: Seoul National University Boramae Hospital | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Status: UNKNOWN